James R Meyers - Net Worth and Insider Trading
James R Meyers Net Worth
The estimated net worth of James R Meyers is at least $227,843 dollars as of 2024-09-20. James R Meyers is the EVP Worldwide Commercial Ops of Gilead Sciences Inc and owns about 2,715 shares of Gilead Sciences Inc (GILD) stock worth over $227,843. Details can be seen in James R Meyers's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James R Meyers has not made any transactions after 2018-01-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James R Meyers
James R Meyers Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James R Meyers owns 4 companies in total, including CytomX Therapeutics Inc (CTMX) , Arbutus Biopharma Corp (ABUS) , and Sangamo Therapeutics Inc (SGMO) among others .
Click here to see the complete history of James R Meyers’s form 4 insider trades.
Insider Ownership Summary of James R Meyers
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
CTMX | CytomX Therapeutics Inc | 2018-12-20 | director |
ABUS | Arbutus Biopharma Corp | 2019-08-17 | director |
SGMO | Sangamo Therapeutics Inc | 2019-11-22 | director |
2018-01-16 | EVP Worldwide Commercial Ops |
James R Meyers Latest Holdings Summary
James R Meyers currently owns a total of 1 stock. James R Meyers owns 2,715 shares of Gilead Sciences Inc (GILD) as of January 16, 2018, with a value of $227,843.
Latest Holdings of James R Meyers
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
GILD | Gilead Sciences Inc | 2018-01-16 | 2,715 | 83.92 | 227,843 |
Holding Weightings of James R Meyers
James R Meyers Form 4 Trading Tracker
According to the SEC Form 4 filings, James R Meyers has made a total of 0 transactions in Gilead Sciences Inc (GILD) over the past 5 years. The most-recent trade in Gilead Sciences Inc is the sale of 100,000 shares on January 16, 2018, which brought James R Meyers around $8 Million.
Insider Trading History of James R Meyers
- 1
James R Meyers Trading Performance
James R Meyers Ownership Network
James R Meyers Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
James R Meyers is the director of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, James R Meyers made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 127,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
James R Meyers Mailing Address
Above is the net worth, insider trading, and ownership report for James R Meyers. You might contact James R Meyers via mailing address: Gilead Sciences, Inc., 333 Lakeside Drive, Foster City Ca 94404.